Ashley Kieran Clift
Clinical Research Fellow
- Clinical Research Fellow, University of Oxford
- Honorary Clinical Research Fellow, Department of Surgery & Cancer, Imperial College London
- Member, COVID risk stratification sub-group of NERVTAG
Ash trained in medicine at Christ Church, University of Oxford, and Imperial College London.
He underwent training as an Academic Foundation Doctor in Nottingham and later, as an Academic Clinical Fellow in General Surgery at Imperial.
His research interests include clinical risk prediction, epidemiology, screening, oncology (particularly neuroendocrine tumours and pancreatic cancers) and the comparison of statistical and machine learning methods in risk modelling.
Using genetics to inform the pharmacological targeting of neuroendocrine neoplasms
Clift AK. and Frilling A., (2020), Endocrine-Related Cancer, 27, R293 - R305
Combining radiolabelled therapies for neuroendocrine neoplasms
Frilling A. and Clift AK., (2020), Nature Reviews Endocrinology, 16, 347 - 348
Neuroendocrine Neoplasms of the Small Bowel and Pancreas
Clift AK. et al, (2020), Neuroendocrinology, 110, 444 - 476
Radioembolisation with 90Y microspheres for neuroendocrine liver metastases: an institutional case series, systematic review and meta-analysis
Frilling A. et al, (2019), HPB, 21, 773 - 783
Functional imaging in liver tumours
Ronot M. et al, (2016), Journal of Hepatology, 65, 1017 - 1030